JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 1


FIGURE 1.  Binding and competition of 125I-labeled p160. (A) Specific binding of 125I-p160 to neuroblastoma WAC 2 cells. Nonspecific binding was determined in presence of unlabeled p160 (10–4 mol/L). The peptides octreotide and D-p160 were used at same concentration (10–4 mol/L) as negative control competitors. (B) Binding of 125I-p160 with and without excess of unlabeled peptide (10–4 mol/L) in WAC 2 and HUVEC cells. Incubation was performed for 1 h at 37°C. (C) Competition for bound 125I-p160 by unlabeled p160 peptide. WAC 2 cells were incubated with 1–2 x 106 cpm radioligand and increasing concentrations of unlabeled p160 peptide. (D) In vitro cell accumulation of 125I-p160 in WAC 2 cells as function of time. Incubation was performed for periods from 5 to 180 min. All experiments were performed in triplicate; SD is shown.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE